A team led by University of Colorado Boulder for TA1 and TA2 is focusing on engineered therapeutic materials. They developed two new therapies that help aging or damaged joints repair themselves within weeks in animal studies. The first technology is a patented particle delivery system that is injected into the joint and provides intermittent bursts of a repurposed, regenerative drug for months. For patients with significant cartilage lesions, the second technology is a cocktail of engineered proteins that are injected arthroscopically and cured into place for focused regeneration. Renovare Therapeutics Inc. has been established as an independent company to commercialize their therapies quickly and accessibly.